[1] BOUVIER A M, MANFREDI S. Epidemiology, risk factors and current screening in rectal cancer[J].Rev Prat,2022, 72(1):32-37.
[2] RAHMA O E, YOTHERS G, HONG T S, et al. Use of total neoadjuvant therapy for locally advanced rectal cancer: Initial results from the pembrolizumab arm of a phase 2 randomized clinical trial[J].JAMA Oncol,2021, 7(8):1225-1230.
[3] SOMA S, GURNULE S. Role of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of rectal cancer[J].South Asian J Cancer,2022, 11(2):118-120.
[4] TRAKARNSANGA A, GÖNEN M, SHIA J, et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment[J].J Natl Cancer Inst,2014, 106(10):248-253.
[5] 宋燕, 王海鹏, 王倩, 等. 3.0TMRI联合HMGB1表达对直肠癌新辅助治疗疗效的评估[J].中华肿瘤防治杂志, 2022, 29(10):763-769.
[6] 李丽娅, 周传集, 赖少侣, 等. ADC和nADC值对局部进展期直肠癌新辅助放化疗疗效评估价值[J].中华肿瘤防治杂志, 2021, 28(24):1902-1908.
[7] WEISMANN C. Ultrasound elastography techniques in breast cancer[J].Radiologe,2021, 61(2):170-176.
[8] PAN H Y, ZHANG Q, WU W J, et al. Preoperative neoadjuvant chemotherapy in patients with breast cancer evaluated using strain ultrasonic elastography[J].World J Clin Cases,2022, 10(21):7293-7301.
[9] 邢国强, 杨怀成, 邓腾, 等. 结直肠癌患者的血清血管内皮生长因子结直肠癌患者的血清血管内皮生长因子、糖类抗原19-9、癌胚抗原水平及与临床特征和预后的关系[J].癌症进展, 2023, 21(4):424-427.
[10] JI L C, GU L Q, ZHANG X P, et al. Evaluation of serum midkine and carcinoembryonic antigen as diagnostic biomarkers for rectal cancer and synchronous metastasis[J].Transl Cancer Res,2020, 9(4):2814-2823.
[11] 辛衡, 周建平, 高威, 等. 结直肠癌患者术前血浆纤维蛋白原、癌胚抗原、糖类抗原19-9水平与临床病理特征的关系[J].中国医科大学学报, 2020, 49(11):1007-1010. |